カテゴリ： QYResearch, 世界, 医療/バイオ

血液腫瘍治療の世界市場2023年：化学療法、標的療法、免疫療法、その他

■ 英語タイトル：Global Blood Tumor Treatment Market Research Report 2023
	■ 発行会社/調査会社：QYResearch ■ 商品コード：QYR23MA8696 ■ 発行日：2023年3月 ■ 調査対象地域：グローバル ■ 産業分野：医薬品 ■ ページ数：88 ■ レポート言語：英語 ■ レポート形式：PDF ■ 納品方式：Eメール（受注後2-3営業日）

■ 販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD2,900 ⇒換算￥440,800	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD4,350 ⇒換算￥661,200	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD5,800 ⇒換算￥881,600	見積依頼/購入/質問フォーム

※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[血液腫瘍治療の世界市場2023年：化学療法、標的療法、免疫療法、その他]についてメールでお問い合わせはこちら

*** レポート概要（サマリー）***

当調査資料は血液腫瘍治療のグローバル市場について調査・分析し、世界の血液腫瘍治療市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（化学療法、標的療法、免疫療法、その他）、用途別セグメント分析（白血病、リンパ腫、多発性骨髄腫、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Bristol-Myers Squibb、Johnson & Johnson、AbbVie、Novartis、Roche、Amgen、Takeda、Pfizer、AstraZeneca、Gilead Sciencesなどが含まれています。血液腫瘍治療のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、血液腫瘍治療市場規模を算出する際に考慮しました。

・血液腫瘍治療市場の概要
- 血液腫瘍治療の種類別セグメント
- 世界の血液腫瘍治療市場規模：タイプ別分析（化学療法、標的療法、免疫療法、その他）
- 血液腫瘍治療の用途別セグメント
- 世界の血液腫瘍治療市場規模：用途別分析（白血病、リンパ腫、多発性骨髄腫、その他）
- 世界の血液腫瘍治療市場規模予測（2018年-2029年）

・血液腫瘍治療市場の成長トレンド
- 血液腫瘍治療の地域別市場規模（2018年-2029年）
- 血液腫瘍治療市場ダイナミクス
- 血液腫瘍治療の業界動向
- 血液腫瘍治療市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：化学療法、標的療法、免疫療法、その他
- 世界の血液腫瘍治療のタイプ別市場規模（2018年-2023年）
- 世界の血液腫瘍治療のタイプ別市場規模（2024年-2029年）

・用途別セグメント：白血病、リンパ腫、多発性骨髄腫、その他
- 世界の血液腫瘍治療の用途別市場規模（2018年-2023年）
- 世界の血液腫瘍治療の用途別市場規模（2024年-2029年）

・血液腫瘍治療の地域別市場規模
- 北米の血液腫瘍治療市場規模（2018年-2029年）
- 米国の血液腫瘍治療市場規模（2018年-2029年）
- ヨーロッパの血液腫瘍治療市場規模（2018年-2029年）
- アジア太平洋の血液腫瘍治療市場規模（2018年-2029年）
- 中国の血液腫瘍治療市場規模（2018年-2029年）
- 日本の血液腫瘍治療市場規模（2018年-2029年）
- 韓国の血液腫瘍治療市場規模（2018年-2029年）
- インドの血液腫瘍治療市場規模（2018年-2029年）
- オーストラリアの血液腫瘍治療市場規模（2018年-2029年）
- 中南米の血液腫瘍治療市場規模（2018年-2029年）
- 中東・アフリカの血液腫瘍治療市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Bristol-Myers Squibb、Johnson & Johnson、AbbVie、Novartis、Roche、Amgen、Takeda、Pfizer、AstraZeneca、Gilead Sciences

・アナリストの観点/結論

・調査手法と情報源

Blood Tumor, also known as hematological disease, is a type of cancer impacting bone marrow, blood, and lymph nodes. Different sorts of mature blood cells include white blood cells for immune protection, platelets for wound clotting, and red blood cells to carry oxygen. In the bone marrow, it originates from progenitor cells and hematopoietic stem. Hematologic malignancies initiate in these cells and are subcategorized as per the type of blood cell that is affected such as myeloid or myelogenous or and lymphocytic lymphoblastic. A malignancy in the lymphoid lineage involves B lymphocytes and T lymphocytes. Malignancy in the myeloid lineage involves precursor cells to white blood cells platelets and red blood cells.
Highlights
The global Blood Tumor Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Blood Tumor Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Blood Tumor Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Blood Tumor Treatment in Leukemia is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Blood Tumor Treatment include Bristol-Myers Squibb, Johnson & Johnson, AbbVie, Novartis, Roche, Amgen, Takeda, Pfizer and AstraZeneca, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Blood Tumor Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Tumor Treatment.
The Blood Tumor Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Blood Tumor Treatment market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blood Tumor Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Bristol-Myers Squibb
Johnson & Johnson
AbbVie
Novartis
Roche
Amgen
Takeda
Pfizer
AstraZeneca
Gilead Sciences
Segment by Type
Chemotherapy
Targeted Therapy
Immunotherapy
Other
Segment by Application
Leukemia
Lymphoma
Multiple Myeloma
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Blood Tumor Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Blood Tumor Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Chemotherapy
1.2.3 Targeted Therapy
1.2.4 Immunotherapy
1.2.5 Other
1.3 Market by Application
1.3.1 Global Blood Tumor Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Leukemia
1.3.3 Lymphoma
1.3.4 Multiple Myeloma
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Blood Tumor Treatment Market Perspective (2018-2029)
2.2 Blood Tumor Treatment Growth Trends by Region
2.2.1 Global Blood Tumor Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Blood Tumor Treatment Historic Market Size by Region (2018-2023)
2.2.3 Blood Tumor Treatment Forecasted Market Size by Region (2024-2029)
2.3 Blood Tumor Treatment Market Dynamics
2.3.1 Blood Tumor Treatment Industry Trends
2.3.2 Blood Tumor Treatment Market Drivers
2.3.3 Blood Tumor Treatment Market Challenges
2.3.4 Blood Tumor Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Blood Tumor Treatment Players by Revenue
3.1.1 Global Top Blood Tumor Treatment Players by Revenue (2018-2023)
3.1.2 Global Blood Tumor Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Blood Tumor Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Blood Tumor Treatment Revenue
3.4 Global Blood Tumor Treatment Market Concentration Ratio
3.4.1 Global Blood Tumor Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Blood Tumor Treatment Revenue in 2022
3.5 Blood Tumor Treatment Key Players Head office and Area Served
3.6 Key Players Blood Tumor Treatment Product Solution and Service
3.7 Date of Enter into Blood Tumor Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Blood Tumor Treatment Breakdown Data by Type
4.1 Global Blood Tumor Treatment Historic Market Size by Type (2018-2023)
4.2 Global Blood Tumor Treatment Forecasted Market Size by Type (2024-2029)
5 Blood Tumor Treatment Breakdown Data by Application
5.1 Global Blood Tumor Treatment Historic Market Size by Application (2018-2023)
5.2 Global Blood Tumor Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Blood Tumor Treatment Market Size (2018-2029)
6.2 North America Blood Tumor Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Blood Tumor Treatment Market Size by Country (2018-2023)
6.4 North America Blood Tumor Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Blood Tumor Treatment Market Size (2018-2029)
7.2 Europe Blood Tumor Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Blood Tumor Treatment Market Size by Country (2018-2023)
7.4 Europe Blood Tumor Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Blood Tumor Treatment Market Size (2018-2029)
8.2 Asia-Pacific Blood Tumor Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Blood Tumor Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Blood Tumor Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Blood Tumor Treatment Market Size (2018-2029)
9.2 Latin America Blood Tumor Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Blood Tumor Treatment Market Size by Country (2018-2023)
9.4 Latin America Blood Tumor Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Blood Tumor Treatment Market Size (2018-2029)
10.2 Middle East & Africa Blood Tumor Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Blood Tumor Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Blood Tumor Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Company Detail
11.1.2 Bristol-Myers Squibb Business Overview
11.1.3 Bristol-Myers Squibb Blood Tumor Treatment Introduction
11.1.4 Bristol-Myers Squibb Revenue in Blood Tumor Treatment Business (2018-2023)
11.1.5 Bristol-Myers Squibb Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Detail
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Blood Tumor Treatment Introduction
11.2.4 Johnson & Johnson Revenue in Blood Tumor Treatment Business (2018-2023)
11.2.5 Johnson & Johnson Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Detail
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Blood Tumor Treatment Introduction
11.3.4 AbbVie Revenue in Blood Tumor Treatment Business (2018-2023)
11.3.5 AbbVie Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Blood Tumor Treatment Introduction
11.4.4 Novartis Revenue in Blood Tumor Treatment Business (2018-2023)
11.4.5 Novartis Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Blood Tumor Treatment Introduction
11.5.4 Roche Revenue in Blood Tumor Treatment Business (2018-2023)
11.5.5 Roche Recent Development
11.6 Amgen
11.6.1 Amgen Company Detail
11.6.2 Amgen Business Overview
11.6.3 Amgen Blood Tumor Treatment Introduction
11.6.4 Amgen Revenue in Blood Tumor Treatment Business (2018-2023)
11.6.5 Amgen Recent Development
11.7 Takeda
11.7.1 Takeda Company Detail
11.7.2 Takeda Business Overview
11.7.3 Takeda Blood Tumor Treatment Introduction
11.7.4 Takeda Revenue in Blood Tumor Treatment Business (2018-2023)
11.7.5 Takeda Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Detail
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Blood Tumor Treatment Introduction
11.8.4 Pfizer Revenue in Blood Tumor Treatment Business (2018-2023)
11.8.5 Pfizer Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Detail
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Blood Tumor Treatment Introduction
11.9.4 AstraZeneca Revenue in Blood Tumor Treatment Business (2018-2023)
11.9.5 AstraZeneca Recent Development
11.10 Gilead Sciences
11.10.1 Gilead Sciences Company Detail
11.10.2 Gilead Sciences Business Overview
11.10.3 Gilead Sciences Blood Tumor Treatment Introduction
11.10.4 Gilead Sciences Revenue in Blood Tumor Treatment Business (2018-2023)
11.10.5 Gilead Sciences Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Blood Tumor Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Targeted Therapy
Table 4. Key Players of Immunotherapy
Table 5. Key Players of Other
Table 6. Global Blood Tumor Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Blood Tumor Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Blood Tumor Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Blood Tumor Treatment Market Share by Region (2018-2023)
Table 10. Global Blood Tumor Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Blood Tumor Treatment Market Share by Region (2024-2029)
Table 12. Blood Tumor Treatment Market Trends
Table 13. Blood Tumor Treatment Market Drivers
Table 14. Blood Tumor Treatment Market Challenges
Table 15. Blood Tumor Treatment Market Restraints
Table 16. Global Blood Tumor Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Blood Tumor Treatment Market Share by Players (2018-2023)
Table 18. Global Top Blood Tumor Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Tumor Treatment as of 2022)
Table 19. Ranking of Global Top Blood Tumor Treatment Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Blood Tumor Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Blood Tumor Treatment Product Solution and Service
Table 23. Date of Enter into Blood Tumor Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Blood Tumor Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Blood Tumor Treatment Revenue Market Share by Type (2018-2023)
Table 27. Global Blood Tumor Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Blood Tumor Treatment Revenue Market Share by Type (2024-2029)
Table 29. Global Blood Tumor Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Blood Tumor Treatment Revenue Market Share by Application (2018-2023)
Table 31. Global Blood Tumor Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Blood Tumor Treatment Revenue Market Share by Application (2024-2029)
Table 33. North America Blood Tumor Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Blood Tumor Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Blood Tumor Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Blood Tumor Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Blood Tumor Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Blood Tumor Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Blood Tumor Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Blood Tumor Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Blood Tumor Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Blood Tumor Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Blood Tumor Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Blood Tumor Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Blood Tumor Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Blood Tumor Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Blood Tumor Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 48. Bristol-Myers Squibb Company Detail
Table 49. Bristol-Myers Squibb Business Overview
Table 50. Bristol-Myers Squibb Blood Tumor Treatment Product
Table 51. Bristol-Myers Squibb Revenue in Blood Tumor Treatment Business (2018-2023) & (US$ Million)
Table 52. Bristol-Myers Squibb Recent Development
Table 53. Johnson & Johnson Company Detail
Table 54. Johnson & Johnson Business Overview
Table 55. Johnson & Johnson Blood Tumor Treatment Product
Table 56. Johnson & Johnson Revenue in Blood Tumor Treatment Business (2018-2023) & (US$ Million)
Table 57. Johnson & Johnson Recent Development
Table 58. AbbVie Company Detail
Table 59. AbbVie Business Overview
Table 60. AbbVie Blood Tumor Treatment Product
Table 61. AbbVie Revenue in Blood Tumor Treatment Business (2018-2023) & (US$ Million)
Table 62. AbbVie Recent Development
Table 63. Novartis Company Detail
Table 64. Novartis Business Overview
Table 65. Novartis Blood Tumor Treatment Product
Table 66. Novartis Revenue in Blood Tumor Treatment Business (2018-2023) & (US$ Million)
Table 67. Novartis Recent Development
Table 68. Roche Company Detail
Table 69. Roche Business Overview
Table 70. Roche Blood Tumor Treatment Product
Table 71. Roche Revenue in Blood Tumor Treatment Business (2018-2023) & (US$ Million)
Table 72. Roche Recent Development
Table 73. Amgen Company Detail
Table 74. Amgen Business Overview
Table 75. Amgen Blood Tumor Treatment Product
Table 76. Amgen Revenue in Blood Tumor Treatment Business (2018-2023) & (US$ Million)
Table 77. Amgen Recent Development
Table 78. Takeda Company Detail
Table 79. Takeda Business Overview
Table 80. Takeda Blood Tumor Treatment Product
Table 81. Takeda Revenue in Blood Tumor Treatment Business (2018-2023) & (US$ Million)
Table 82. Takeda Recent Development
Table 83. Pfizer Company Detail
Table 84. Pfizer Business Overview
Table 85. Pfizer Blood Tumor Treatment Product
Table 86. Pfizer Revenue in Blood Tumor Treatment Business (2018-2023) & (US$ Million)
Table 87. Pfizer Recent Development
Table 88. AstraZeneca Company Detail
Table 89. AstraZeneca Business Overview
Table 90. AstraZeneca Blood Tumor Treatment Product
Table 91. AstraZeneca Revenue in Blood Tumor Treatment Business (2018-2023) & (US$ Million)
Table 92. AstraZeneca Recent Development
Table 93. Gilead Sciences Company Detail
Table 94. Gilead Sciences Business Overview
Table 95. Gilead Sciences Blood Tumor Treatment Product
Table 96. Gilead Sciences Revenue in Blood Tumor Treatment Business (2018-2023) & (US$ Million)
Table 97. Gilead Sciences Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Blood Tumor Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Blood Tumor Treatment Market Share by Type: 2022 VS 2029
Figure 3. Chemotherapy Features
Figure 4. Targeted Therapy Features
Figure 5. Immunotherapy Features
Figure 6. Other Features
Figure 7. Global Blood Tumor Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Blood Tumor Treatment Market Share by Application: 2022 VS 2029
Figure 9. Leukemia Case Studies
Figure 10. Lymphoma Case Studies
Figure 11. Multiple Myeloma Case Studies
Figure 12. Others Case Studies
Figure 13. Blood Tumor Treatment Report Years Considered
Figure 14. Global Blood Tumor Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Blood Tumor Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Blood Tumor Treatment Market Share by Region: 2022 VS 2029
Figure 17. Global Blood Tumor Treatment Market Share by Players in 2022
Figure 18. Global Top Blood Tumor Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Tumor Treatment as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Blood Tumor Treatment Revenue in 2022
Figure 20. North America Blood Tumor Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Blood Tumor Treatment Market Share by Country (2018-2029)
Figure 22. United States Blood Tumor Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Blood Tumor Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Blood Tumor Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Blood Tumor Treatment Market Share by Country (2018-2029)
Figure 26. Germany Blood Tumor Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France Blood Tumor Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. Blood Tumor Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy Blood Tumor Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia Blood Tumor Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries Blood Tumor Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Blood Tumor Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Blood Tumor Treatment Market Share by Region (2018-2029)
Figure 34. China Blood Tumor Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Japan Blood Tumor Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. South Korea Blood Tumor Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Southeast Asia Blood Tumor Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. India Blood Tumor Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Australia Blood Tumor Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Blood Tumor Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Blood Tumor Treatment Market Share by Country (2018-2029)
Figure 42. Mexico Blood Tumor Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Brazil Blood Tumor Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Blood Tumor Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Blood Tumor Treatment Market Share by Country (2018-2029)
Figure 46. Turkey Blood Tumor Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Saudi Arabia Blood Tumor Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Bristol-Myers Squibb Revenue Growth Rate in Blood Tumor Treatment Business (2018-2023)
Figure 49. Johnson & Johnson Revenue Growth Rate in Blood Tumor Treatment Business (2018-2023)
Figure 50. AbbVie Revenue Growth Rate in Blood Tumor Treatment Business (2018-2023)
Figure 51. Novartis Revenue Growth Rate in Blood Tumor Treatment Business (2018-2023)
Figure 52. Roche Revenue Growth Rate in Blood Tumor Treatment Business (2018-2023)
Figure 53. Amgen Revenue Growth Rate in Blood Tumor Treatment Business (2018-2023)
Figure 54. Takeda Revenue Growth Rate in Blood Tumor Treatment Business (2018-2023)
Figure 55. Pfizer Revenue Growth Rate in Blood Tumor Treatment Business (2018-2023)
Figure 56. AstraZeneca Revenue Growth Rate in Blood Tumor Treatment Business (2018-2023)
Figure 57. Gilead Sciences Revenue Growth Rate in Blood Tumor Treatment Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/

H&I Global Research

血液腫瘍治療の世界市場2023年：化学療法、標的療法、免疫療法、その他

グローバル市場調査会社